ScienceTechyNews: Statin add-on may offer new/another option for reducing LDL-C in high-risk patients

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or 'bad' cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

by